Sanofi Joins Hands with German Biotech to Develop Improved AAV Capsids for Gene Therapies
On February 23, Munich-based SIRION Biotech GmbH announced signing a license and collaboration agreement with Sanofi. The agreement intends to harness SIRION’s capabilities as a leader in viral vector-based gene …
Read More